IP Tokens of IPNFT #129 (CLAW)

IP Tokens of IPNFT #129 (CLAW) represent an innovative approach to funding and supporting research in the field of cognitive health and neurodegenerative disease management. This unique token is part of a larger initiative driven by the CerebrumDAO, which is dedicated to advancing brain health through community collaboration and decentralized governance. CLAW aims to facilitate funding for the development of Percepta®, a patented dietary supplement designed to combat cognitive decline and memory loss, utilizing active ingredients such as PTI-00703® Cat’s Claw and MemorTea®, a specific oolong tea extract.

The potential market for brain health supplements is expansive, with predictions indicating significant growth within the sector. As institutions increasingly recognize the correlation between aging populations and the rising incidence of cognitive disorders, products like Percepta® could emerge as key players in this burgeoning $8.6 billion market. Drawing on preclinical evidence, the initiative aims to yield tangible human outcomes, with a focus on achieving FDA botanical drug status, thereby underscoring the commercial viability and transformative potential of these innovative health solutions.

Ongoing research and development efforts associated with CLAW are tailored to meet critical milestones, including detailed studies to validate the effectiveness of Percepta®. These studies are designed to establish a strong foundation for broader clinical applications, reinforcing the commitment to scientific rigor and evidence-based outcomes. By engaging a community of researchers, funders, and advocates, CLAW not only seeks to promote innovative solutions for cognitive health but also aims to create a decentralized platform that empowers stakeholders in the realm of neuroscience and brain health.